What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis?

被引:184
作者
Davin, JC
ten Berge, IJ
Weening, JJ
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
关键词
vasculitis; crescents; immunological abnormalities; allergy; leukocytes; circulating chemokines; hypersensitivity;
D O I
10.1046/j.1523-1755.2001.00565.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Henoch-Schonlein purpura nephritis (HSPN) and IgA nephropathy (IgAN) are considered to be related diseases since both can be encountered consecutively in the same patient, they have been described in twins, and bear identical pathological and biological abnormalities. Apart from the presence of extrarenal clinical signs found only in HSPN, other differences are noticed between the two diseases. The peak age ranges between 15 and 30 years for a diagnosis of IgAN, whereas HSPN is mainly seen in childhood. Nephritic and/or nephrotic syndromes are more often seen at presentation in HSPN. In contrast to IgAN, HSPN has been described in association with hypersensitivity. Endocapillary and extracapillary inflammations as well as fibrin deposits in the glomerulus are more frequent in HSPN. No major biological differences have been found between the two illnesses, except for a larger size of circulating IgA-containing complexes (IgA-CC) and a greater incidence of increased plasma IgE levels in HSPN. As tissue infiltration by leukocytes is a major feature of HSPN vasculitis, a possible role of a more potent activation of the latter cells by IgA-CC and/or circulating chemokines in HSPN should be considered. Further studies are required to elucidate this possible mechanism as well as the role of hypersensitivity in HSPN.
引用
收藏
页码:823 / 834
页数:12
相关论文
共 148 条
[11]   AUTOLOGOUS MIXED LYMPHOCYTE-REACTION AND T-CELL SUPPRESSOR ACTIVITY IN PATIENTS WITH HENOCH-SCHONLEIN PURPURA AND IGA NEPHROPATHY [J].
CASANUEVA, B ;
RODRIGUEZVALVERDE, V ;
FARINAS, MC ;
VALLO, A ;
RODRIGUEZSORIANO, J .
NEPHRON, 1990, 54 (03) :224-228
[12]   FIBRONECTIN-IMMUNOGLOBULIN COMPLEXES IN THE EARLY COURSE OF IGA AND HENOCH-SCHONLEIN NEPHRITIS [J].
CEDERHOLM, B ;
LINNE, T ;
WIESLANDER, J ;
BYGREN, P ;
HEINEGARD, D .
PEDIATRIC NEPHROLOGY, 1991, 5 (02) :200-204
[13]   IMPAIRMENT OF LUNG DIFFUSION CAPACITY IN SCHONLEIN-HENOCH PURPURA [J].
CHAUSSAIN, M ;
DEBOISSIEU, D ;
KALIFA, G ;
EPELBAUM, S ;
NIAUDET, P ;
BADOUAL, J ;
GENDREL, D .
JOURNAL OF PEDIATRICS, 1992, 121 (01) :12-16
[14]  
CHEVALIER X, 1995, CLIN NEPHROL, V43, P348
[15]  
CLARKSON AR, 1987, IGA NEPHROPATHY, P9
[16]  
Cohen Tervaert J.W., 1991, KLIN IMMUNOLOGIE, P216
[17]  
COPPO R, 1984, CLIN EXP IMMUNOL, V57, P583
[18]   Long-term prognosis of Henoch-Schonlein nephritis in adults and children [J].
Coppo, R ;
Mazzucco, G ;
Cagnoli, L ;
Lupo, A ;
Schena, FP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) :2277-2283
[19]   CIRCULATING IMMUNE-COMPLEXES AND IMMUNOGLOBULIN-A RHEUMATOID-FACTOR IN PATIENTS WITH MESANGIAL IMMUNOGLOBULIN-A NEPHROPATHIES [J].
CZERKINSKY, C ;
KOOPMAN, WJ ;
JACKSON, S ;
COLLINS, JE ;
CRAGO, SS ;
SCHROHENLOHER, RE ;
JULIAN, BA ;
GALLA, JH ;
MESTECKY, J .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1931-1938
[20]  
DAMICO G, 1984, NEPHROLOGY, P686